DEPARTMENT NAME
Department of Pediatrics, Oncology, Hematology and Diabetology

CONTACT DETAILS FOR HEAD OF DEPARTMENT
Wojciech Mlynarski, MD, PhD
[email protected]
+48 42 61 77 791
Department of Pediatrics, Oncology, Hematology and Diabetology
Sporna 36/50
91-738 Lodz, Poland

TEAM MEMBERS
Wojciech Mlynarski, MD, PhD
Agata Pastorczak MD, PhD
Szymon Janczar MD, PhD
Joanna Trelińska MD, PhD
Agnieszka Zmyslowska MD, PhD
Beata Mianowska MD, PhD
Katarzyna Bąbol-Pokora MD, PhD – Head of The Laboratory of Immunopathology and Genetics
Joanna Taha MD, PhD – Head of OncoLab

SHORT DESCRIPTION OF RESEARCH ACTIVITY
Primary Immunodeficiencies, PID, SCID, Lymphoproliferative Syndrome, ALPS, Neutropenia, SCN, HLH, FHL, Next Generation Sequencing, NGS, SNP-array ALL, epigenetics, histones, chromatin, minimal residual disease, MRD Tuberous sclerosis, pathogenesis, signalling pathway, microRNA, metabolome, Genetic determinants of haemophilia comorbidities and treatment, factor VIII inhibitor, factor VIII pharmacokinetics, Monogenic diabetes, Wolfram syndrome, new technologies, artificial pancreas, education

DEPARTMENTAL ACHIEVEMENTS: PROJECTS AND PAPERS
Searching for progression markers in Wolfram syndrome patients

The role and prognostic significance of genetic aberrations in acute lymphoblastic leukemia (ALL)

Comprehensive analysis of the genetic causes of female hemophilia in Poland

Personalization of childhood acute lymphoblastic leukemia treatment in Poland

Analysis of F8 mutations , HLA alleles and disease-associated exonic mutations to predict coagulation factor VIII inhibitor development and pharmacokinetics in patients with haemophilia A

“CLOSE: Automated glucose control at home for people with chronic disease” – EIT Health innovation project by design

Zmysłowska A. Fendler W. et al. Retinal thinning as a marker of disease progression in patients with Wolfram syndrome. Diabetes Care: 2015 : Vol. 38, nr 3, e36-37,

Janczar S., Fogtman A. , Koblowska M. et al,. Novel severe hemophilia A and moyamoya (SHAM) syndrome caused by Xq28 deletions encompassing F8 and BRCC3 genes. Blood. 2014 Jun 19;123(25):4002-4